help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 3, 2005
Endocrinology, doi:10.1210/en.2004-1161
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/5/2462    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yehuda-Shnaidman, E.
Right arrow Articles by Bar-Tana, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yehuda-Shnaidman, E.
Right arrow Articles by Bar-Tana, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A
*LIOTHYRONINE

Submitted on August 31, 2004
Accepted on January 26, 2005

Modulation of mitochondrial transition pore components by thyroid hormone

Einav Yehuda-Shnaidman, Bella Kalderon, and Jacob Bar-Tana*

Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, Israel 91120

* To whom correspondence should be addressed. E-mail: bartanaj{at}cc.huji.ac.il.

Thyroid hormone (TH) modulates metabolic efficiency by controlling the coupling of mitochondrial oxidative phosphorylation. However, its uncoupling mode of action is still enigmatic. Treatment of Jurkat or GH3 cells by triiodothyronine (T3) is reported here to result in limited, cyclosporin A-sensitive mitochondrial depolarization, conforming to low-conductance gating of the mitochondrial transition pore (MTP). MTP protein components induced by T3 treatment were verified in T3-treated and hypothyroid rat liver as well as in Jurkat cells. T3 treatment resulted in increase in mitochondrial bax and bak together with decreased mitochondrial bcl2. T3-induced mitochondrial depolarization was aborted by over expression of bcl2. In contrast to Bax-Bcl2 family proteins, some other MTP components were either not induced by T3 (e.g. voltage-dependent anion channel (VDAC)) or were induced but not involved in cyclosporin A-sensitive MTP gating (e.g. cyclophilin D, adenine nucleotide translocase2) Hence, TH-induced mitochondrial uncoupling may be ascribed to low-conductance MTP gating mediated by TH-induced increase in mitochondrial proapoptotic combined with decrease in mitochondrial antiapoptotic proteins of the Bax-Bcl2 family.


Key words: Thyroid hormone • mitochondrial transition pore • mitochondrial depolarization • bcl2 family proteins • cyclophilin D • adenine nucleotide translocase




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Siculella, S. Sabetta, A. M. Giudetti, and G. V. Gnoni
Hypothyroidism Reduces Tricarboxylate Carrier Activity and Expression in Rat Liver Mitochondria by Reducing Nuclear Transcription Rate and Splicing Efficiency
J. Biol. Chem., July 14, 2006; 281(28): 19072 - 19080.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society